Herbalife Ltd.: The Share Price Is Discounting Terminal Decline

Herbalife Ltd. is rated a 'risky' Buy, with shares trading at a steep discount and the market pricing in an overly pessimistic perpetual decline. HLF posted four consecutive quarters of YoY net sales growth, driven mainly by a one-off India GST cut, while other regions showed mixed or declining volume trends. Strategic repositioning toward personalized nutrition and deleveraging efforts are underway, with net leverage reduced to 2.2x and $45M in annual cash interest savings unlocked. Despite risks from GLP-1 adoption, growth concentration, leverage, and regulatory exposure, the current price offers potential upside versus a base case fair value near $24.

I rate Herbalife Ltd. ( HLF ) with a “risky” Buy. The company has now registered four consecutive quarters of YoY growth in net sales, with Q2 2026 sales that were up 5.4%, beating consensus, while the